Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Artificial Lung Market Poised To Hit $4.27 Billion By 2030 With A 10.4% CAGR
The artificial lung market has seen substantial growth in recent times. Its valuation is expected to climb from $2.58 billion in 2025 to $2.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. This historical expansion can be attributed to several factors, including an increase in acute respiratory failure cases, the early incorporation of heart-lung machines in cardiothoracic operations, a rise in organ transplant procedure volumes, the evolution of membrane artificial lung technology, and the expanding application of extracorporeal life support systems.
The artificial lung market size is expected to experience substantial growth in the next few years. It is projected to reach $4.27 billion in 2030, achieving a compound annual growth rate (CAGR) of 10.4%. The anticipated expansion during the forecast period can be attributed to an increasing need for critical care life-support devices, a growing emphasis on portable and compact artificial lung systems, rising investment in advanced oxygenation membrane materials, the expansion of applications within emergency and trauma care, and the increasing adoption of minimally invasive extracorporeal support solutions. Key trends during this period include a surging demand for artificial lung systems in cases of severe respiratory failure and critical care management, the rising utilization of extracorporeal support devices in intricate cardiac and lung transplant surgeries, a growing inclination towards minimally invasive and temporary lung support options as alternatives to transplantation, the increasing development of portable and transport-compatible artificial lung units for emergency care settings, and the expanding deployment of membrane-based artificial lung technologies for efficient gas exchange and long-term support.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Lung Market Industry Drivers: What’s Behind The Revenue Growth?
The artificial lung market is expected to expand in the future due to the increasing incidence of respiratory ailments. The rise in respiratory diseases is attributed to a combination of factors, including growing air pollution, climate change, and evolving lifestyle habits, all of which contribute significantly to public health concerns. Artificial lungs are utilized in these conditions to provide oxygenation and remove carbon dioxide from the blood, either supporting or replacing compromised lung function. For example, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, estimated that approximately 8.5 million people in Australia, or 34% of the population, had chronic respiratory conditions. This included an estimated 2.8 million people, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Thus, the growing prevalence of respiratory diseases is driving the expansion of the artificial lung market.
Artificial Lung Market Segment Analysis Spotlighting Growth Areas
The artificial lung market covered in this report is segmented –
1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung
2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications
3) By End-Users: Hospital, Emergency Center, Other End-users
Subsegments:
1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines
3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung
4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung
#Artificial Lung Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies within the artificial lung market are concentrating on developing innovative solutions, such as truly portable pneumatic ECMO systems, to broaden extracorporeal life support beyond the ICU and facilitate quick transport and deployment in the field. A pneumatic portable ECMO system operates using oxygen-supply-driven pneumatic pumps and integrated gas management to deliver extracorporeal oxygenation and circulatory assistance, without relying on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, reported that MOBYBOX, the world’s first integrated portable pneumatic ECMO system, had finished its initial commercial applications in Europe; MOBYBOX weighs about 2.5 kg, is powered solely by the oxygen supply, allowing it to function without a battery or motor, incorporates Bionique Flow Technology for softer blood handling and better gas exchange, and has obtained Medical Device Regulation certification for its introductory markets.
Artificial Lung Market Key Participants And Competitive Landscape
Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB‑Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation
View The Full Artificial Lung Market Report:
Artificial Lung Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
